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the following response options: “completely agree,” “somewhat agree,” “somewhat disagree,” “completely
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Abstract
Background: Assisted dying and continuous deep sedation 
(CDS) are controversial practices. Little is known about the 
perceptions of physicians and surrogates about these prac-
tices for patients with advanced dementia. Objectives: To 
describe and compare physician and surrogate agreement 
with the use of assisted dying and CDS in advanced demen-
tia. Design, Setting, Subjects: Physicians (n = 64) and surro-
gates (n = 168) of persons with advanced dementia were re-
cruited as part of a randomized controlled trial in Switzer-
land that tested decision support tools in this population. 
Methods: At baseline, the participants were asked about 
their agreement with assisted dying and CDS in advanced 
dementia using the following response options: “complete-
ly agree,” “somewhat agree,” “somewhat disagree,” “com-
pletely disagree,” and “do not know.” Multivariable logistic 
regressions compared the likelihood that surrogates versus 
physicians would completely or somewhat agree (vs. com-
pletely or somewhat disagree) with these practices. Results: 
The physicians and surrogates, respectively, had a mean age 
(SD) of 50.6 years (9.9) and 57.4 years (14.6); 46.9% (n = 30/64) 
and 68.9% (n = 115/167) were women. A total of 20.3% (n = 
13/64) of the physicians and 47.0% (n = 79/168) of the sur-
rogates agreed with assisted dying in advanced dementia. 
Surrogates were significantly more likely to agree with this 
practice than physicians (adjusted odds ratio, 3.87; 95% CI: 
1.94, 7.69). With regard to CDS, 51.6% (n = 33/64) of the phy-
sicians and 41.9% (n = 70/169) of the surrogates agreed with 
this practice, which did not differ significantly between the 
groups. Conclusions: The surrogates were more agreeable 
to considering assisted dying in the setting of advanced de-
mentia than the physicians, and about half of the partici-
pants in both groups reported CDS to be an appropriate op-

























































































Dementia afflicts more than 50 million people world-
wide and is one of the most common causes of death in 
Switzerland [1, 2]. In advanced dementia, patients have 
profound cognitive and functional deficits, and they ex-
perience clinical complications that may cause discom-
fort and a poor quality of life [3–5].
Assisted dying is a controversial practice that has 
been used in certain contexts for patients with life-lim-
iting disease [6]. Assisted dying is when a physician ei-
ther administers drugs that cause a person to die (i.e., 
euthanasia) or provides lethal drugs for self-administra-
tion (i.e., physician-assisted suicide) [7]. In the case of 
euthanasia, the physician takes an active role in com-
pleting the request of the patient incapable of complet-
ing the final act, for instance, by administering a lethal 
injection. In assisted suicide, the physician solely makes 
lethal means available to the patient, but the completion 
of the final act is left to the patient. Currently, physician-
assisted dying is legal in only a few states in the USA as 
well as in a limited number of countries, including Swit-
zerland [6, 8, 9]. However, only the Netherlands, Bel-
gium, and Luxembourg allow assisted dying for people 
with advanced dementia [10]. This request must be 
made in an advance directive by a patient with dementia 
when decision-making capacity is still intact. Only lim-
ited research exists on the perceptions of physicians and 
surrogates about the use of assisted dying in advanced 
dementia [11–15].
Another controversial practice for terminally ill pa-
tients is continuous deep sedation (CDS) until death, a 
last-resort palliative practice to alleviate suffering [16, 
17]. Medications are administered until death to low-
er  the level of consciousness and relieve refractory 
symptoms of patients with a life expectancy of typically 
less than 2 weeks [18]. To date, CDS has predominant-
ly been used for advanced cancer patients who are ex-
periencing extreme physical suffering in their final 
weeks of life [16, 19]. CDS has rarely been used in ad-
vanced dementia, a condition predominantly charac-
terized by cognitive impairments, with some, but typi-
cally less, physical suffering than metastatic cancer [3, 
5, 20].
To better understand the perceptions of physi-
cians  and surrogates about the use of assisted dying 
and  CDS in advanced dementia, we analyzed base-
line  data from a randomized controlled trial, the 
 DEMentia FACT boxes (DEMFACT) Study, conducted 
in the Swiss German region of Switzerland. The objec-
tives of this report were to (1) describe physician 
and surrogate agreement with the use of assisted dying 
and CDS in advanced dementia, and (2) compare the 




The data were retrieved from baseline assessments made in 
the DEMFACT Study, conducted between June 2016 and Octo-
ber 2016 in the Swiss German region of Switzerland. DEMFACT 
was a randomized controlled trial that evaluated FACT box de-
cision support tools for treatment decision-making regarding 
advanced dementia among 64 physicians and 168 surrogates 
(relatives of dementia patients, n = 100; professional guardians, 
n = 68) who were randomized to either an intervention arm (n 
= 114) or a control arm (n = 118) [21]. The participants in the 
intervention and control arms were mailed written question-
naires at baseline and 1 month later that included questions 
about the use of treatments for advanced dementia patients 
based on hypothetical scenarios. At the 1-month follow-up, the 
intervention participants received the decision support tools, 
whereas the control participants were given no additional infor-
mation.
The main DEMFACT Study compared changes in prespecified 
outcomes between the baseline and follow-up assessments in the 
intervention arm relative to the control arm. In this report, com-
bined data from the baseline questionnaires in both arms (i.e., be-
fore receiving the decision support tools in the intervention arm) 
were analyzed to describe agreement with the use of continuous 
sedation and assisted dying in advanced dementia. The baseline 
questionnaires were completed between June 2, 2016, and July 31, 
2016.
Population
To understand the impact of the DEMFACT intervention on 
various decision-makers, the participants included physicians as 
well as surrogates (relatives of dementia patients and professional 
guardians) who were potentially responsible for the care of ad-
vanced dementia patients. Physicians were identified from the 
mailing lists of the Swiss Association for Palliative Medicine, Care 
and Support, and the Swiss Geriatric Medicine Society. Surrogates 
were identified either through the Alzheimer Association of the 
canton of Zurich or from the Swiss Association of Professional 
Guardians mailing list. The detailed recruitment procedure is de-
scribed elsewhere [21]. Eligible participants were mailed a consent 
form, which they were asked to sign and return to the research 
team.
Data Elements
Data collection was procedurally identical across physician 
and surrogate participants. All variables in this report were col-
lected at the DEMFACT baseline assessment using a written 

























































































The outcomes were participants’ agreement with the use of as-
sisted dying and CDS in advanced dementia. Agreement with as-
sisted dying was ascertained using the following question: “The 
current legislation prohibits physician-assisted suicide (assisted 
dying) for persons lacking the capacity to consent. This prevents 
persons with advanced dementia from accessing the services of 
assisted dying organizations. Independent of the current legal sit-
uation, would you personally support the use of assisted suicide 
(one form of physician-hastened death) for persons with ad-
vanced dementia?” Agreement with the use of CDS was measured 
as follows: “At the end of  life, it is possible to use medications, 
administered until death, to relieve the symptoms of a person with 
advanced dementia and put them into a permanent, artificial 
sleep (continuous sedation). Would you personally support the 
use of continuous  sedation for persons with advanced dementia?” 
For both questions, the participants were asked to select one of the 
following response options: “completely agree,” “somewhat 
agree,” “somewhat disagree,” “completely disagree,” or “do not 
know.”
Other participant data assessed at baseline included demo-
graphics (age, gender, nationality [Swiss, German, and other], re-
ligion [Protestant or Catholic, other religion, no religion, and re-
fused to answer], and educational level [≥high school vs. other]) 
and whether participants had previously decided about the use of 
antibiotics and/or artificial hydration for a person with advanced 
dementia.
Analysis
The analyses were performed using R version 3.3.2 
 (Boston, MA, USA). Means with standard deviations (SDs) and 
frequencies describe continuous and categorical variables, re-
spectively.
Logistic regression was used to examine the association be-
tween decision-maker type (surrogate vs. physician) and agree-
ment with the following practices in advanced dementia (out-
comes): (1) assisted dying and (2) CDS. For each practice, the 
outcome was dichotomized as “agree” (i.e., “completely agree” 
and “somewhat agree”) versus “disagree” (i.e., “completely dis-
agree” and “somewhat disagree”) and excluded “do not know” 
responses. Covariates considered a priori to be possibly associ-
ated with supporting the use of assisted dying or CDS [13] in-
cluded participants’ demographic characteristics (age [dichoto-
mized at the median], gender, and religion [dichotomized as 
“no  religion” vs. “any,” excluding “refused to answer”]) and 
 prior decisions about the use of antibiotics and/or artificial hy-
dration in advanced dementia (dichotomized as “any prior 
 major treatment decision” vs. “none”). Bivariable analyses ex-
amined the unadjusted associations between each covariate and 
the outcome. Variables associated with the outcome at p < 0.10 
in the unadjusted analyses were entered into a multivariable 
model. The final adjusted model included those variables sig-
nificantly associated with the outcome at p < 0.05. Adjusted odds 
ratios (AORs) with 95% confidence intervals (CIs) were com-
puted. A sensitivity analysis examined whether the association 
differed as a function of subgroup (relatives vs. proxies), since 




Of the 3,860 individuals approached for participa-
tion, 254 (6.6%) contacted the research team indicating 
their willingness to participate, and all were eligible for 
enrollment. Prior to study completion, 15 participants 
(5.9%) stopped responding to e-mails and/or phone 
calls (physicians, n = 9/74 [12.2%]; surrogates, n = 6/180 
[3.3%]) and 7 participants (2.8%) withdrew (physicians, 
n = 1/74 [1.4%]; surrogates, n = 6/180 [3.3%]). The final 
sample included the remaining 64 physicians and 168 
surrogates.
The baseline characteristics of the physicians and sur-
rogates are shown in Table 1. The physicians’ mean age 
(SD) was 50.6 years (9.9); 46.9% (n = 30/64) were women 
and 72.1% (n = 44/61) were Swiss. The surrogates’ mean 
age (SD) was 57.4 years (14.6); 68.9% (n = 115/167) were 
women and 94.6% (n = 157/166) were Swiss. A total of 
68.8% (n = 44/64) of the physicians and 65.5% (n = 
108/165) of the surrogates reported being either Protes-
tant or Catholic. A total of 90.6% (n = 58/64) of the physi-





Mean age ± SDa, years 50.6±9.9 57.4±14.6
Age >55 yearsb 21 (32.8) 91 (54.5)
Femalea 30 (46.9) 115 (68.9)
Nationalitya
Swiss 44 (72.1) 157 (94.6)
German 13 (21.3) 7 (4.2)
Other 4 (6.6) 2 (1.2)
Religiona
Protestant or catholic 44 (68.8) 108 (65.5)
Other 9 (14.1) 11 (6.7)
No religion 10 (15.6) 38 (23.0)
Refused to answer 1 (1.6) 8 (4.8)
Educationa
High school or higher 64 (100) 161 (97.0)
Any prior major treatment 
decision in dementiaa, c 58 (90.6) 42 (25.3)
Values denote n (%) unless specified otherwise. a  The total 
number of missing values by characteristic was: age, n = 1; female, 
n = 1; nationality, n = 5; religion, n = 3; education, n = 2; and any 
prior major treatment decision, n = 2. b Median age. c Decision-
makers reported whether they had or had not previously made any 
major decision about the use of antibiotics and/or artificial 
























































































cians had previously made a major treatment decision for 
a person with advanced dementia, whereas only 25.3% 
(n = 42/166) of the surrogates had ever made such a deci-
sion.
Agreement with Assisted Dying
The distribution of physician responses about the use 
of assisted dying in advanced dementia was as follows: 
completely agree, 4.7% (n = 3/64); somewhat agree, 15.6% 
(n = 10/64); somewhat disagree, 26.6% (n = 17/64); com-
pletely disagree, 50.0% (n = 32/64); and do not know, 
3.1% (n = 2/64). The distribution among the surrogates 
was: completely agree, 20.2% (n = 34/168); somewhat 
agree, 26.8% (n = 45/168); somewhat disagree, 23.2% (n = 
39/168); completely disagree, 22.6% (n = 38/168); and do 
not know, 7.1% (n = 12/168).
In the unadjusted analyses, participant variables as-
sociated with agreement with assisted dying at p < 0.10 
were: age > 55 years; any prior major treatment decision 
in dementia; and being a surrogate (vs. a physician) (Ta-
ble 2). After multivariable adjustment, only being a sur-
rogate (vs. a physician) remained significantly associat-
ed with a higher likelihood of agreeing with the use of 
assisted dying (AOR, 3.87; 95% CI: 1.94, 7.69). When 
analyzing surrogate subgroups, agreement was signifi-
cantly more likely among relatives than among proxies 
(34.6 vs. 16.0%; AOR, 2.00; 95% CI: 1.04, 3.83) (Appen-
dix, Table 1).
Agreement with CDS
The distribution of physician responses about the use 
of CDS in advanced dementia was as follows: completely 
agree, 20.3% (n = 13/64); somewhat agree, 31.3% (n = 
20/64); somewhat disagree, 31.3% (n = 20/64); complete-
ly disagree, 6.3% (n = 4/64); and do not know, 10.9% (n = 
7/64). The distribution among the surrogates was: com-
pletely agree, 12.6% (n = 21/167); somewhat agree, 29.3% 
(n = 49/167); somewhat disagree, 28.7% (n = 48/167); 
completely disagree, 18.6% (n = 31/167); and do not 
know, 10.8% (n = 18/167).
The only covariate associated with a greater likeli-
hood of supporting the use of CDS at p ≤ 0.10 was “no 
religion” (vs. “any”) (Table 3). After adjusting for reli-
gion, being a surrogate (vs. a physician) remained not 
significantly associated with agreement with the use of 
CDS (AOR, 0.69; 95% CI: 0.36, 1.29). When analyzing 
surrogate subgroups, agreement was significantly 
more likely among relatives than among proxies (34.9 
vs. 12.1%; AOR, 2.82; 95% CI: 1.41, 5.64) (Appendix, 
Table 2).
Discussion
In this report, a minority of the physicians (20%) and 
about half of the surrogates (47%) supported the use of 
assisted dying for patients with advanced dementia. Sur-








dying (n = 92), n (%)
Odds ratioa for agreement







Surrogate (vs. physician) 156 (71.6) 79 (36.2) 13 (6.0) 3.87 (1.94, 7.69)d 3.87 (1.94, 7.69)
Covariates
Age >55 yearsb 106 (48.8) 54 (24.9) 38 (17.5) 1.99 (1.15, 3.45)d
Femaleb 133 (61.3) 62 (28.6) 30 (13.8) 1.57 (0.90, 2.76)
No religion (vs. any)b 45 (21.4) 24 (11.4) 67 (31.9) 1.67 (0.86, 3.24)
Any prior major treatment decision 
in dementiab, c 97 (44.9) 29 (13.4) 61 (28.2) 0.41 (0.23, 0.71)d
Decision-makers: 42.2% (n = 92/218) agreed with the use of assisted dying in advanced dementia. a Logistic regression was used in 
all analyses, and unadjusted and adjusted odds ratios were computed. b The total number of missing values was: age, n = 1; female, n = 
1; no religion, n = 8 (missing values, n = 3; refused, n = 5); and any prior major treatment decision, n = 2. c Decision-makers reported 
whether they had or had not previously made any major decision about the use of antibiotics and/or artificial hydration for a person 
























































































rogates were significantly more likely to agree with the 
use of this practice than physicians. About half of the phy-
sicians (52%) and a slightly lower proportion of the sur-
rogates (42%) agreed with the use of CDS for these pa-
tients, which was not a significant difference between the 
groups.
This study confirms and extends the limited existing 
research on the perceptions of physicians and surrogates 
about assisted dying in advanced dementia [11–15]. The 
use of assisted dying has increased in countries where it 
is legal (The Netherlands and Belgium) over the last de-
cade, but much less frequently for patients with demen-
tia than for those with terminal illnesses that do not im-
pact decision-making abilities [6, 10, 22]. Prior research 
has shown that most physicians are opposed to the use 
of this practice in dementia [12–15]. Irrespective of the 
presence of an advance directive, physicians are reluctant 
to perform physician-assisted suicide for patients lacking 
decision-making capacity [12]. A Dutch study on 1,456 
physicians found that physicians were more willing to 
perform assisted dying for cancer patients with intact 
cognition (85%) than for advanced dementia patients 
who had requested euthanasia in an advance directive 
prepared when they were still capable of making medical 
decisions (33%) [14]. Similar proportions were found in 
a recent Canadian study on 136 physicians [15]. Notably, 
this study also showed that agreement increased to 71% 
when the hypothetical scenario specified that the demen-
tia patients were in their last days of life. One chief con-
cern is that preferences change over time [23], and that 
patients who imagine a future state with advanced de-
mentia as one not worth living, once in that state, may 
appear to still retain a desire to live. Although surrogates 
may share this concern, their more favorable view of the 
use of assisted dying may be driven by a relatively great-
er aversion to their loved one experiencing the poor 
quality of life, suffering, and indignities of advanced de-
mentia [11, 13]. The greater likelihood of surrogates 
agreeing to assistance in dying is due to the fact that their 
participation, unlike physicians, is not required to com-
plete the act.
Our findings build on the very limited data on the use 
of CDS in advanced dementia [3, 15, 20], and they reveal 
that there is no consensus among either physicians or 
surrogates about the appropriateness of using CDS in 
this population. This finding corroborates qualitative 
research showing that both groups of key decision-mak-
ers have mixed feelings about the use of this practice 
among terminally ill patients [24, 25]. To date, CDS has 
predominantly been used and studied in advanced can-
cer, a condition where decision-making capacity re-
mains intact and the dying process is most commonly 




(n = 206), n (%)
Decision-makers agreeing 
with continuous deep 
sedation (n = 103), n (%)
Odds ratioa for agreement with 







Surrogate (vs. physician) 149 (72.3) 70 (34.0) 33 (16.0) 0.64 (0.35, 1.19) 0.69 (0.36, 1.29)e
Covariates
Age >55 yearsb 101 (49.3) 55 (26.8) 48 (23.4) 1.39 (0.81, 2.42)
Femaleb 128 (62.4) 64 (31.2) 39 (19.0) 0.97 (0.55, 1.71)
No religion (vs. any)b 41 (20.9) 27 (13.8) 74 (37.8) 2.11 (1.03, 4.33)d 2.19 (1.06, 4.51)
Any prior major treatment 
decision in dementiab, c 88 (43.1) 47 (23.0) 55 (27.0) 1.27 (0.73, 2.22)
Decision-makers: 50.0% (n = 103/206) agreed with the use of continuous deep sedation in advanced dementia. a Logistic regression 
was used in all analyses, and unadjusted and adjusted odds ratios were computed. b The total number of missing values was: age, n = 1; 
female, n = 1; no religion, n = 10 (missing values, n = 2; refused, n = 8); and any prior major treatment decision, n = 2. c Decision-makers 
reported whether they had or had not previously made any major decision about the use of antibiotics and/or artificial hydration for a 
person with advanced dementia. d The only variable that was significant at p < 0.10 in the bivariable analyses and entered into the 
multivariable model. e After adjusting for religion, the association between being a surrogate and agreement with the use of continuous 
























































































accompanied by intractable physical pain and suffering 
[16, 19]. In contrast to these patients, advanced demen-
tia patients cannot participate in decision-making or re-
port the source of their discomfort due to their serious 
cognitive impairments [5]. Therefore, it may be chal-
lenging for physicians to assess the intensity of a pa-
tient’s suffering, making it difficult to justify the use of 
CDS in advanced dementia. Furthermore, pain and agi-
tation in advanced dementia are often caused by other 
medical complications, such as infections, and may be 
effectively controlled with standard palliative medica-
tions [3, 4].
This study has several limitations that merit discus-
sion. First, our participation rate was low, and thus our 
findings cannot be generalized to eligible nonpartici-
pants. Second, generalizability is also limited to the 
Swiss German region of Switzerland and to hypothetical 
situations. The perceptions about end-of-life practices 
may vary in other regions of Switzerland and in real-life 
situations. In addition, it cannot be ruled out that physi-
cians unaffiliated with associations promoting palliative 
care may hold different views on end-of-life practices. 
Third, the questions may not have been detailed enough 
to detect nuances in participants’ perceptions [26]. It is 
likely that participants’ opinions would have been dif-
ferent if they had been given more information, such as 
a statement indicating that the patient had made a writ-
ten request for assisted dying before losing decision-
making capacity. Likewise, providing participants with 
background information and definitions of different 
end-of-life practices such as physician-assisted suicide 
and euthanasia in the case of incompetent patients 
would likely have altered the responses. Lastly, the sta-
tistical power may have been insufficient to detect sig-
nificant differences in secondary outcomes, notably dif-
ferences in perceptions about CDS. Future work should 
replicate these findings in a clinical cluster-randomized 
trial.
This study expands upon the limited existing litera-
ture on the perceptions of physicians and surrogates 
about the use of assisted dying and CDS for patients with 
advanced dementia. Physicians were more opposed to 
the use of assisted dying than were the surrogates, and 
about half of the participants in both groups perceived 
CDS as an appropriate option in advanced dementia. In 
general, there is a clear need to improve end-of-life care 
in this patient population. However, due to the practical, 
ethical, and legal issues associated with performing as-
sisted dying and CDS for patients who lack decision-
making capacity, it remains unclear whether these prac-
tices would help accomplish this goal. Early goals of care 
discussions can promote decisions that align with the pa-
tient’s preferences and the use of standard palliative 
medications [27, 28].
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Table 1. Association between being a relative versus a proxy and agreement with the use of assisted dying in advanced dementia
Surrogates with the 
characteristic 
(n = 156), n (%)
Surrogates agreeing with assisted
dying (n = 79), n (%)
Odds ratioa for
agreement with assisted 
dying (95% CI)
characteristic present characteristic absent adjustedb
Characteristic
Relative (vs. proxy) 94 (60.3) 54 (34.6) 25 (16.0) 2.00 (1.04, 3.83)
Surrogates: 50.6% (n = 79/156) agreed with the use of assisted dying in advanced dementia. a Logistic regression was used in all 
analyses, and unadjusted and adjusted odds ratios were computed. b After accounting for age, gender, religion, and prior decisions about 
antibiotics/artificial hydration use, no variables were significant at p < 0.10 in the bivariable analyses, except for the association between 
being a relative versus proxy and agreement with the use of assisted dying in advanced dementia.
Table 2. Association between being a relative versus a proxy and agreement with the use of continuous deep sedation in advanced 
dementia
Surrogates with the 
characteristic 
(n = 149), n (%)
Surrogates agreeing with
continuous deep sedation (n = 70), n (%)
Odds ratioa for agreement 
with continuous deep 
sedation (95% CI)
characteristic present characteristic absent adjustedb
Characteristic
Relative (vs. proxy) 92 (61.7) 52 (34.9) 18 (12.1) 2.82 (1.41, 5.64)
Surrogates: 47.0% (n = 70/149) agreed with the use of continuous deep sedation in advanced dementia. a Logistic regression was used 
in all analyses, and unadjusted and adjusted odds ratios were computed. b After accounting for age, gender, religion, and prior decisions 
about antibiotics/artificial hydration use, no variables were significant at p < 0.10 in the bivariable analyses, except for the association 
between being a relative versus proxy and agreement with the use of continuous deep sedation in advanced dementia.
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